CITRONOWICZ MOSHE 4

What Happened Moshe Citronowicz, Senior Vice President of Operations at Apyx Medical (APYX), was granted 63,392 derivative securities (reported as an award) on 2026-06-11. The Form 4 records the acquisition at $0.00 (derivative), indicating an option/award rather than an open-market purchase or sale. Per the filing footnote, the award vests ratably over a 36-month period and becomes fully vested on the third anniversary of the grant date.

Key Details

• Transaction date: 2026-06-11; Transaction type: A (award/grant/other acquisition).
• Reported price: $0.00 on the Form 4 (typical reporting for grants; not a cash purchase).
• Shares/options granted: 63,392.
• Vesting: Ratably over 36 months; fully vested on the 3rd anniversary (per footnote).
• Shares owned after transaction: Not specified in the provided summary.
• Filing date: 2026-06-15 — filed on the Form 4 deadline (generally within two business days), so not late.

Context This was an equity award/option grant, not an exercise or sale. Awards that vest over time are common as retention/incentive compensation and do not represent an immediate market buy or sell by the insider. For investors, note that such grants may lead to future dilution if exercised and that the grant’s terms (exercise price, expiration) and the company’s equity plan should be reviewed for full impact.